Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 19:12:135.
doi: 10.4103/abr.abr_1_23. eCollection 2023.

The Role of Dyslipidemia in Atherogenesis in Peritoneal Dialysis Patients

Damir Rebić  1 , Edin Begić  2   3 , Buena Aziri  3 , Alen Džubur  4 , Ena Gogić  4 , Azra Durak-Nalbantić  4 , Aida Hamzić-Mehmedbašić  1 , Senad Hasanspahić  1 , Nermir Granov  5
Affiliations

The Role of Dyslipidemia in Atherogenesis in Peritoneal Dialysis Patients

Damir Rebić et al. Adv Biomed Res. .

Abstract

Background: To evaluate atherosclerotic changes in carotid arteries (CCA) in uremic patients before and after 18 months of continuous ambulatory peritoneal dialysis (CAPD) treatment, and to evaluate the impact of dyslipidemia and CAPD treatment on vascular remodeling.

Materials and methods: We conducted a longitudinal, prospective study during 2020 and 2021 at the Clinic for Nephrology, Clinical Center University of Sarajevo. Patients with end-stage renal disease were included and were followed during 18 months of CAPD treatment. All patients were treated using commercially prepared biocompatible balanced dialysis solutions. Carotid intima-media thickness (IMT) and atherosclerotic plaques on the common carotid artery (CCA) were measured by echotomography.

Results: A total of 50 patients were included and were followed during 18 months of CAPD treatment. Lipid values in the serum of patients with CAPD were significantly lower after 18 months of CAPD treatment compared to the values before treatment, while the value of high-density lipoprotein (HDL) was significantly increased after 18 months of CAPD treatment. The values of IMT and the diameter of the CCA compared to the basal values were significantly lower (P < 0.001).

Conclusion: We demonstrated significantly lower lipid values and higher HDL levels following CAPD treatment. Correct selection of the targeted pharmacological intervention can substantially impact the regression of vascular changes in patients on peritoneal dialysis.

Keywords: Atherosclerosis; carotid intima-media thickness; dyslipidemia; end-stage renal disease; peritoneal dialysis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696–707. - PubMed
    1. Ortiz A, Wanner C, Gansevoort R. ERA Council, Chronic kidney disease as cardiovascular risk factor in routine clinical practice: A position statement by the Council of the European Renal Association. Eur J Prev Cardiol. 2022;29:2211–5. - PubMed
    1. El Chamieh C, Liabeuf S, Massy Z. Uremic toxins and cardiovascular risk in chronic kidney disease: What have we learned recently beyond the past findings? Toxins (Basel) 2022;14:280. - PMC - PubMed
    1. Zanoli L, Mikhailidis DP. Narrative review of carotid disease and the kidney. Ann Transl Med. 2021;9:1210. - PMC - PubMed
    1. Foudi N, Palayer M, Briet M, Garnier AS. Arterial remodelling in chronic kidney disease: Impact of uraemic toxins and new pharmacological approaches. J Clin Med. 2021;10:3803. - PMC - PubMed